GAZELLE, NCT03817853: An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma |
|
|
| Completed | 4 | 114 | Europe, Japan, US, RoW | Obinutuzumab, GA101, RO5072759, Bendamustine, Cyclophosphamide, Doxorubicin, Prednisone/Prednisolone/Methylprednisolone, Vincristine | Hoffmann-La Roche | Advanced Follicular Lymphoma | 08/20 | 01/23 | | |
2018-003255-38: A Study of Gazyva Short Duration Infusion (SDI) in Patients with Previously Untreated Follicular Lymphoma |
|
|
| Not yet recruiting | 4 | 112 | Europe | Obinutuzumab, RO5072759, Concentrate for solution for infusion, Gazyvaro | F. Hoffmann-La Roche Ltd, F. Hoffmann-La Roche Ltd | Follicular lymphoma, Follicular lymphoma (FL) is one of the most common common B cell-indolent non-Hodgkin's lymphomas (NHL) [type of blood cell cancer of the immune system], Diseases [C] - Cancer [C04] | | | | |
